David Shook - Jul 1, 2023 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Role
Chief Medical Officer
Signature
/s/ Alicia Hager, as Attorney-in-Fact
Stock symbol
NKTX
Transactions as of
Jul 1, 2023
Transactions value $
$0
Form type
4
Date filed
7/5/2023, 04:06 PM
Previous filing
Jun 22, 2023
Next filing
Aug 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTX Stock Option (right to buy) Award $0 +208K $0.00 208K Jul 1, 2023 Common Stock 208K $2.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2023.